Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 1, 1997, Pages 55-65

  Crabos, Maryse ^a   Coste, Pierre ^a   Paccalin, Marc ^a   Tariosse, Liliane ^a   Daret, Danièle ^a   Besse, Pierre ^a   Bonoron Adèle, Simone ^a  

^a INSERM   (France)

Author keywords

Cardiac hypertrophy; Coronary circulation; Endothelium; Hypertension; Immunohistochemistry; Intramyocardial microvessels; Nitric oxide; Nitric oxide synthase

Indexed keywords

ADENOSINE; BRADYKININ; COLLAGEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY MEDIA; ARTICLE; BLOOD VESSEL DIAMETER; COMPUTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY BLOOD VESSEL; ENZYME INHIBITION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

EID: 0030892661     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0251     Document Type: Article

References (49)

1. AMANN K, GHAREHBAGHI H, STEPHAN S, MALL G, 1995. Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats. Hypertension 25: 124-131.
2. ANDERSON PG, BISHOP SP, DIGERNESS SB, 1989. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. Circ Res 64: 1127-1136.
3. ANTONY I, LEREBOURS G, NITENBERG A, 1995. Loss of flow-dependent coronary artery dilatation in patients with hypertension. Circulation 91: 1624-1628.
4. BALLIGAND JL, KOBZIK L, HAN X, KAYE DM, BELHASSEN L, O'HARA DS, KELLY RA, SMITH TW, MICHEL T, 1995. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (TypeIII) nitric oxide synthase in cardiac myocytes. J Biol Chem 270: 14582-14586.
5. BRILLA CG, JANICKI JS, WEBER KT, 1991. Impaired diastolic function and coronary reserve in genetic hypertension. Circ Res 69: 107-115.
6. CLOZEL M, KUHN H, HEFTI F, 1990. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16: 532-540.
7. CLOZEL JP, VÉNIANT M, HESS P, SPRECHER U, 1991. Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats. Hypertension 18: II-8-II-14.
8. DANIEL-LAMAZIÈRE JM, LAVALLÉE J, ZUNINO C, LARRUE J, 1993. Semiquantitative study of the distribution of two cellular antigens by computer-directed color analysis. Lab Invest 68: 248-252.
9. DOMINICZAK AF, BOHR DF, 1995. Nitric oxide and its putative role in hypertension. Hypertension 25: 1202-1211.
10. EGASHIRA K, SUZUKI S, HIROOKA Y, KAI H, SUGIMACHI M, IMAIZUMI T, TAKESHITA A, 1995. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension 25: 201-206.
11. FURCHGOTT RF, ZAWADZKI JV, 1980. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
12. GIAID A, SALEH D, 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214-221.
13. HALLER H, BEHREND M, PARK JK, SCHABERG T, LUFT FC, DISTLER A, 1995. Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats. Hypertension 25: 132-138.
14. INOUE N, VENEMA RC, SAYEGH HS, OHARA Y, MURPHY TJ, HARRISON DG, 1995. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-b1. Arterioscler Thromb Vasc Biol 15:1255-1261.
15. ISOYAMA S, ITO N, SATOH K, TAKISHIMA T, 1992. Collagen deposition and the reversal of coronary reserve in cardiac hypertrophy. Hypertension 20: 491-500.
16. JALIL JE, JANICKI JE, PICK R, WEBER KT, 1991. Coronary vascular remodeling and myocardial flbrosis in the rat with renovascular hypertension. Am J Hypertens 4: 51-55.
17. JONES LF, BRODY MJ, 1992. Coronary blood flow in rats is dependent on the release of vascular nitric oxide. J Pharmacol Exp Ther 260: 627-631.
18. JONES CJH, KUO L, DAVIS MJ, CHILIAN WM, 1995. Regulation of coronary blood flow: coordination of heterogeneous control mechanisms in vascular microdomains. Cardiovasc Res 29: 585-596.
19. KELM M, FEELISCH M, KREBBER T, DEUSSEN A, MOTZ W, STRAUER BE, 1995. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Hypertension 25: 186-193.
20. KIRKEBOEN KA, NAESS PA, OFFSTAD J, ILEBEKK A, 1994. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am J Physiol 266: H1516-H1527.
21. KOLLER A, HUANG A, 1994. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 74: 416-421.
22. LAMONTAGNE D, POHL V, BUSSE R, 1992. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70: 123-130.
23. LIAO J, SHIN W, LEE W, CLARK S, 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270: 319-324.
24. LINDER L, KIOWSKI W, BÜHLER FR, LÜSCHER TF, 1990. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 81: 1762-1767.
25. LÜSCHER TF, NOLL G, 1994. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol 24: S16-S26.
26. LÜSCHER TF, VANHOUTTE PM, 1986. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8: 344-348.
27. MALINSKI T, KAPTURCZAK M, DAYHARSH J, BOHR D, 1993. Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194: 654-658.
28. MCQUILLAN LP, LEUNG GK, MARSDEN PA, KOSTYK SK, KOUREMBANAS S, 1994. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 267: H1921-H1927.
29. MONCADA S, PALMER RMJ, HIGGS A, 1991. Nitric oxide: physiology, patho-physiology, and pharmacology. Pharmacol Rev 43: 109-142.
30. NAVA E, NOLL G, LÜSCHER TF, 1995. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91: 2310-2313.
31. NICOLETTI A, HEUDES D, HINGLAIS N, APPAY MA, PHILIPPE M, SASSY-PRIGENT C, BARIETY J, MICHEL JP, 1995. Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone. Hypertension 26: 101-111.
32. PALMER RM, FERRIGE AG, MONCADA S, 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
33. PANZA JA, GARCIA CE, KILCOYNE CM, QUYYUMI AA, CANNON RO, 1995. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 91: 1732-1738.
34. POHL U, LAMONTAGNE D, BASSENGE E, BUSSE R, 1994. Attenuation of coronary autoregulation in the isolated rabbit heart by endothelium derived nitric oxide. Cardiovasc Res 28: 414-419.
35. QUYYUMI AA, DAKAK N, ANDREWS NP, HUSAIN S, ARORA S, GILLIGAN DM, PANZA JA, CANNON RO, 1995. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 95: 1747-1755.
36. RANJAN V, XIAO Z, DIAMOND SL, 1995. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol 269: H550-H555.
37. REES DD, PALMER RMJ, SCHULZ R, HODSON HF, MONCADA S, 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752.
38. RUBANYI GM, ROMERO JC, VANHOUTTE PM, 1986. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250: H1145-H1149.
39. RUBBOLI A, SOBOTKA PA, EULER DE, 1994. Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am J Physiol 267: H1054-H1061.
40. SESSA W, PRITCHARD K, SEYEDI N, WANG J, HINTZE TH, 1994. Chronic exercise in dogs increases coronary nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74: 349-353.
41. SMITH REA, PALMER RMJ, BUCKNALL CA, MONCADA S, 1992. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc Res 26: 508-512.
42. SMITH CJ, SUN D, HOEGLER C, ROTH BS, ZHANG X, ZHAO G, XU XB, KOBARI Y, PRITCHARD K, SESSA WC, HINTZE TH, 1996. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 78: 58-64.
43. TOMANEK RJ, AYDELOTTE MR, BUTTERS C, 1990. Late-onset renal hypertension in old rats alters myocardial microvessels. Am J Physiol 259: H1681-H1687.
44. TREASURE CB, KLEIN JL, VITA JA, MANOUKIAN SV, RENWICK GH, SELWYN AP, GANZ P, ALEXANDER RW, 1993. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87: 86-93.
45. UEEDA M, SILVIA SK, OLSSON RA, 1992. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res 70: 1296-1303.
46. VANHOUTTE PM, HOUSTON DS, 1985. Platelets, endothelium and vasospasm. Circulation 72: 728-734.
47. VANHOUTTE PM, 1988. The endothelium: modulator of vascular smooth muscle tone. N Engl J Med 319: 512-513.
48. WANGLER RD, PETERS KG, MARCUS ML, TOMANEK RJ, 1982. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 51: 10-18.
49. YOSHIZUMI M, PERRELLA MA, BURNETT JC, LEE M, 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209.